Frontlight ResearchEarly access
Enrolling by invitationNo phase
Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials
Key facts
- Who runs it
- Ramon Diaz-Arrastia
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 215 people, planned
- Started
- 3 Sept 2026
- Expected to end
- 31 Jul 2030
- Type of study
- Observational, 2 groups
- Treatments tested
- Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)
- Record updated
- 30 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Age 18 years and older
- Evidence of mechanical energy impacting the head or inertial forces affecting the head
- Either (A) or (B):; Trauma-related abnormality on CT scan on admission; If CT normal, documented/verified TBI based on evidence of either loss of consciousness, post-traumatic amnesia, confusion, or post-traumatic symptoms
- Age 18 years and older
- No history of TBI in the past 12 months
Who cannot take part
- Subjects with magnetic-sensitive devices implanted in their head or within 12 in. (30 cm) of the coil/probe (examples: cochlear implants, deep brain stimulators, vagus nerve stimulators, other implanted electrodes/stimulators, aneurysm clips or coils, stents and bullet fragments)
- Subjects with magnetic-sensitive devices implanted in their head or within 12 in. (30 cm) of the coil/probe (examples: cochlear implants, deep brain stimulators, vagus nerve stimulators, other implanted electrodes/stimulators, aneurysm clips or coils, stents and bullet fragments)
- History of disabling pre-existing neurologic disease (Such as epilepsy, brain tumors, meningitis, cerebral palsy, encephalitis, brain abscesses, vascular malformations, cerebrovascular disease, Alzheimer's disease, multiple sclerosis, or HIV-encephalitis)
- History of premorbid disabling condition that interfere with outcome assessments
- History of disabling pre-existing neurologic disease (Such as epilepsy, brain tumors, meningitis, cerebral palsy, encephalitis, brain abscesses, vascular malformations, cerebrovascular disease, Alzheimer's disease, multiple sclerosis, or HIV-encephalitis)
- History of premorbid disabling condition that interfere with outcome assessments
- Bilaterally absent pupillary responses
- Penetrating traumatic brain injury
- Prisoners or patients in police custody
- Pregnancy
- Prisoners or patients in police custody
- Pregnancy
Where in United States
- University of PennsylvaniaPhiladelphia, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
Patients evaluated at Penn Presbyterian Medical Center for traumatic brain injury (TBI), who sign the informed consent, will undergo assessment of electrophysiologic potentials evoked by transcranial magnetic stimulation (TMS), using the Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel).
The 2 groups in the trial
- Traumatic Brain Injury (Acute, Subacute, Chronic)
Treatment: Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)
- Healthy Control
Treatment: Delphi-MD device (QuantalX Neuroscience Ltd., Saba Israel)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked Potentials (TMS-EEG)
- Record updated
- 30 October 2026